fig1

Recent progress on tyrosine kinase inhibitors resistance in renal cell carcinoma: another brick in the wall?

Figure 1. TKIs used in the treatment of RCC and their mechanisms. Created in BioRender. Dong, Z. (2025) https://BioRender.com/34g6akl. TKIs: Tyrosine kinase inhibitors; RCC: renal cell carcinoma.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/